Sunday, December 4, 2022
HomeNurses Note Quick ListDilated Cardiomyopathy Causes Diagnosis...

Dilated Cardiomyopathy Causes Diagnosis Treatment by NJE

Dilated cardiomyopathy describes a group of diseases involving the myocardium and is characterized by myocardial dysfunction that is not wholly the result of hypertension, coronary atherosclerosis, valvular dysfunction, congenital, or other structural heart disease. As a result, the heart is enlarged and the ventricles are dilated with impaired systolic function.


1. The estimated prevalence of dilated cardiomyopathy in the general adult population is approximately 1:2500. The incidence is approximately 4 to 8 per 100,000 persons per yr.

2. The incidence of dilated cardiomyopathy is greatest in middle age and among men.

3. African Americans have a three-fold increased risk for developing DCM, irrespective of comorbidities or socioeconomic factors, compared with whites.

4. It is the most common cardiomyopathy and accounts for 25% of cases of congestive heart.


The patient will present with common symptoms of congestive heart failure, which may be of insidious or sudden onset. The patient may also be asymptomatic and the diagnosis made by the unexpected finding of cardiomegaly on a chest x-ray. The history should focus also on information that could help determine the etiology. Classical signs of heart failure may be absent. When present, findings are indistinguishable from other heart failure syndromes, including:

1. Increased jugular venous pressure.

2. Narrow pulse pressure.

3. Pulmonary rales, hepatomegaly, peripheral edema.

4. S3, S4.

5. Mitral regurgitation, tricuspid regurgitation (less common).


In approximate order of occurrence:

1. Idiopathic (often a viral infection that cannot be confirmed)

2. Infections (viral [human herpesvirus 6, influenza, echovirus, cytomegalovirus, Coxsackie B, adenovirus, parvovirus, HIV], rickettsial, mycobacterial, toxoplasmosis, trichinosis, Chagas’ disease)

3. Alcoholism (15% to 40% of all cases in Western countries)

4. Uncontrolled tachyarrhythmia (“tachycardia-mediated”)

5. Sleep apnea–obstructive or nonobstructive

6. Cirrhotic–not necessarily alcohol-induced

7. End-stage renal disease-related

8. Nutritional deficiencies–selenium, L-carnitine, thiamine

9. Peripartum (greatest risk from last trimester of pregnancy to 6 months postpartum)

10. Chemotherapeutic (anthracycline, doxorubicin, daunorubicin) or pharmacologic agents (antiretrovirals, phenothiazines)

11. Substance abuse (cocaine, heroin, organic solvents “glue sniffer’s heart”)

12. Postmyocarditis

13. Toxins (cobalt, lead, phosphorus, carbon monoxide, mercury) Collagen-vascular disease (systemic lupus, rheumatoid arthritis, polyarteritis, dermatomyositis, sarcoidosis)

14. Heredofamilial neuromuscular disease (e.g., muscular dystrophy)

15. Excess hormones (acromegaly, osteogenesis imperfecta, myxedema, thyrotoxicosis, diabetes)

16. Hematologic (e.g., sickle cell anemia, hemochromatosis, hypereosinophilia)

17. Stress-induced (i.e., takotsubo or broken heart syndrome)

18. LV noncompaction

19. TTN truncating mutations (mutations in TTN, the gene encoding the sarcomere protein titin are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic dilated cardiomyopathy and in 18% of sporadic cases.


Dilated cardiomyopathy is a diagnosis of exclusion, made after ruling out other potential causes of myocardial dysfunction.


• Coronary atherosclerosis, that is, left ventricular dysfunction secondary to ischemia and/or myocardial infarction

• Valvular dysfunction (especially aortic and mitral regurgitation)

• Other cardiomyopathies (restrictive, hypertrophic)

• Pulmonary disease (embolism, obstructive, restrictive).

• Pericardial abnormalities (constrictive pericarditis, tamponade)

• Hypothyroidism/myxedema

• Athlete’s heart


• Medical history: emphasis on symptoms of dyspnea, orthopnea, paroxysmal nocturnal dyspnea, weight gain, palpitations, or signs of systemic and pulmonary embolism, substance abuse history, possible toxin exposures (especially occupational).

• Physical exam.

• Testing: laboratory, chest x-ray, ECG, echocardiogram, cardiac catheterization; myocardial biopsy is not routinely recommended unless acute myocarditis requiring immunosuppressive therapy is considered (e.g., giant cell myocarditis).


• Chemistries/metabolites (deficiencies), renal function tests (renal dysfunction).

• Cardiac biomarkers (elevation of cardiac troponin or BNP).

          1. Persistently increased cardiac troponin T levels are a marker of poor outcome in cardiomyopathy patients.

• Endocrine (particularly thyroid).

• Iron studies (hemochromatosis, deficiency).

• Rheumatologic and inflammatory (ANA, ESR, CRP).

• Others as indicated (HIV, Lyme, neurohormonal).


Chest x-ray:

 • Cardiac silhouette enlargement (particularly 

left ventricle)

 • Pulmonary vascular redistribution and congestion (Kerley B lines, cephalization of vasculature), pleural effusion (may appear as unilateral, most often on the right side)


• ECG findings are typically nonspecific, and sinus tachycardia is usually a reflection of underlying heart failure. Large voltage in precordial leads and low voltage in limb leads may be seen in advanced disease.

• Intraventricular conduction defects and left bundle branch block

• Arrhythmias (atrial fibrillation, premature ventricular or atrial contractions, ventricular tachycardia)


• Low ejection fraction with global hypokinesis

• Four-chamber enlargement (LV enlargement usually predominates)

• Mitral or tricuspid regurgitation (tethering due to incomplete leaflet closure caused by ventricular dilation)

Cardiac catheterization:

• On initial presentation to exclude obstructive epicardial coronary artery disease Cardiac magnetic resonance imaging (CMRI):

• Particularly if infiltrative or inflammatory etiology suspected.



• Treatment of underlying disease (systemic lupus, alcoholism)

• Dietary sodium restriction (<2 g/day)

• Exercise training has been shown to be associated with reduced risk for hospitalization and death in patients with history of heart failure in limited trials; enrollment in a formal cardiac rehabilitation program may be beneficial in improving patient’s functional status.


• Identify and treat the etiology of the acute exacerbation, when able. A helpful mnemonic is a FAILURE: failure to take medications, anemia/ arrhythmia, ischemia/infection/infarction, lifestyle (dietary indiscretion), upregulation of cardiac output (hyperthyroidism or pregnancy), renal failure, embolus (pulmonary).

• Diuretics are indicated for all patients with current symptoms or history of heart failure and reduced left ventricular ejection fraction (LVEF) with evidence of volume overload to improve symptoms. It is important to note that diuretics have not been shown to improve mortality rates.

• Patients with associated coronary atherosclerosis (angina, ECG changes, reversible defects on myocardial perfusion imaging) may benefit from percutaneous or surgical revascularization.


• Diuretics and digoxin as noted in “Acute General Rx.”

• ACE inhibitors (and angiotensin receptor blockers) have been shown to have favorable effects on ventricular remodeling in patients with cardiomyopathy and a demonstrable mortality benefit in these patients. They also reduce afterload and improve cardiac output. Therefore, they are recommended in all patients with reduced LV systolic function (EF ≤40%), regardless of symptoms unless specific contraindications exist.

• Beta-blockers work by inhibiting the adverse effects of the sympathetic nervous system in patients with ventricular systolic dysfunction (EF ≤40%). Only carvedilol, long-acting metoprolol succinate, and bisoprolol have shown a mortality benefit in patients with LV systolic dysfunction. Unless specifically contraindicated, they should be started after the acute exacerbation has resolved and titrated to the maximum tolerated dose.

• Aldosterone antagonists (spironolactone and eplerenone) have shown mortality benefit along with a decreased rate of hospitalization for heart failure in patients with symptomatic heart failure and reduced LV systolic function (EF ≤35%). They should be used following label guidelines and with close monitoring of renal function and potassium.

• Additional medical therapies (hydralazine/ nitrates, digitalis) can be considered in certain patient subpopulations with persistent symptoms on otherwise optimal medical management.

• Digoxin has no mortality benefit but has been shown to improve patients’ quality of life in appropriately selected patients.

• The angiotensin receptor-neprilysin inhibitor sacubitril/valsartan in place of an ACE inhibitor or angiotensin receptor blocker and on top of optimal medical therapy in patients with class II-IV heart failure and an EF of 40% or less was found to significantly reduce multiple heart failure endpoints, including death, hospitalizations, and CV death in comparison to enalapril. This medication was approved in the U.S. in 2015.

• Ivabradine was FDA approved in 2015 for patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤35% who are in sinus rhythm with resting heart rates ≥70 beats/min and either of the following:

 (1) are on maximally tolerated doses of beta-blockers or (2) have a contraindication to beta-blocker use. It acts by blocking the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel responsible for the cardiac pacemaker current, which regulates heart rate.

- A word from our sponsors -


Most Popular


Please enter your comment!
Please enter your name here

More from Author

Specimen Collection Papanicolaou (Pap) Smear: Overview, Indication, Procedure

Specimen Collection Papanicolaou (Pap) Smear: The Pap smear is a tool...

Tracheostomy Dressing Care: Procedure and Indications

A tracheostomy is a surgical opening into the trachea and hence a potential route of infection, so the area should be kept clean. Tracheostomies can also cause damage to the surrounding tissues through pressure and the presence of irritant secretions

- A word from our sponsors -


Intestinal Obstruction: Types, Causes, Symptoms, Diagnosis, Management, Complications Nursing Diagnosis

Intestinal obstruction is an interruption in the normal flow of intestinal contents along the intestinal tract. The block may occur in the small or large intestine, may be complete or incomplete, may be mechanical or paralytic, and may or may not compromise the vascular supply. Obstruction most...

Specimen Collection Papanicolaou (Pap) Smear: Overview, Indication, Procedure

Specimen Collection Papanicolaou (Pap) Smear: The Pap smear is a tool for screening of cervical cancer. Appropriate smear collection is paramount to the detection of cancer cells. In addition, if a lesion is seen or palpated, other tests, such as an ultrasound examination of the pelvis or...

Tracheostomy Dressing Care: Procedure and Indications

A tracheostomy is a surgical opening into the trachea and hence a potential route of infection, so the area should be kept clean. Tracheostomies can also cause damage to the surrounding tissues through pressure and the presence of irritant secretions


Nursing Mock Test, Nursing MCQ, DHA HAADMOH PROMETRIC AIIMS ESI NHM NURSING EXAM PREPARATIONNursing Exam PreparationNursing Mock Test SeriesNursing Online ExaminationFree Nursing exam questions

Appendicitis: Causes, Symptoms, Diagnosis, Management, Nursing Interventions

Appendicitis is inflammation of the vermiform appendix caused by an obstruction of the intestinal lumen from infection, stricture, faecal mass, foreign body, or tumour.

Induction of labour: Indications, Method, Management, Complications, Bishop score

Induction of labour is initiated using mechanical and pharmacological methods. The intervention is necessary when the well-being of the mother or baby may be at risk if the pregnancy is continued. The parents should be in agreement and fully informed of the procedures.Indications of Labour• Post-maturity. • PROM...


Nursing Mock Test, Nursing MCQ, DHA HAADMOH PROMETRIC AIIMS ESI NHM NURSING EXAM PREPARATION NO: 09Nursing Exam PreparationNursing Mock Test SeriesNursing Online ExaminationFree Nursing exam questions

Psoriasis: Symptoms, Causes, Diagnosis, Treatment

Psoriasis is a chronic skin disorder characterized by excessive proliferation of keratinocytes, resulting in the formation of thickened scaly plaques, itching, and inflammatory changes of the epidermis and dermis. The various forms of psoriasis include guttate, pustular, and arthritis variants.SIGNS AND SYMPTOMS OF PSORIASIS• Approximately 85% of...

Ovarian Cancer: Causes, Symptoms, Diagnosis, Management, Nursing Diagnosis

Ovarian cancer is a gynecologic malignancy with high mortality because of advanced disease by time of diagnosis. It is the leading cause of morbidity of gynecologic cancers. Pathophysiology and Causes of Ovarian Cancer 1. Median age is 60 years. One of 70 women will develop ovarian cancer.  2. Cause is...

Pericardiocentesis: Preparation Procedure Complications

Pericardiocentesis: Echocardiography-directed pericardial drainage is required for cardiac tamponade due to excess pericardial fluid and to obtain samples of pericardial fluid for the purposes of investigation.Preparation and equipment required for PericardiocentesisEstablish peripheral venous access, and check that full facilities for resuscitation are available. Pre-prepared pericardiocentesis sets may...

Hysteroscopy: Test Overview, Indication, Procedure, Normal Findings, Complication

Hysteroscopy test allows direct visualization of the endometrial cavity. It is indicated for women with an abnormal Papanicolaou (Pap) test, dysfunctional uterine bleeding, or postmenopausal bleeding.NORMAL FINDINGS OF HYSTEROSCOPYNormal structure and function of the uterus.TEST EXPLANATION OF HYSTEROSCOPYHysteroscopy is an endoscopic procedure that provides direct visualization...

Levothyroxine: Action, Uses, Dosage, Side Effects Nursing Consideration

Levothyroxine: CLASSIFICATION: PHARMACOTHERAPEUTIC: Synthetic isomer of thyroxine. CLINICAL: Thyroid hormone (T4).USES OF LEVOTHYROXINELevothyroxine: PO treatment of hypothyroidism, pituitary thyroid-stimulating hormone (TSH) suppression. IV: Myxedema coma. OFF LABEL: Management of hemodynamically unstable potential organ donors.ACTION OF LEVOTHYROXINEConverts to T3, then binds to thyroid receptor proteins exerting...